A targeted next‐generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice

Conventional cytogenetics can categorize patients with acute myeloid leukemia (AML) into favorable, intermediate, and unfavorable‐risk groups; however, patients with intermediate‐risk cytogenetics represent the major population with variable outcomes. Because molecular profiling can assist with AML...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Med
Auteurs principaux: Lin, Po‐Han, Li, Huei‐Ying, Fan, Sheng‐Chih, Yuan, Tzu‐Hang, Chen, Ming, Hsu, Yu‐Hua, Yang, Yu‐Hsuan, Li, Long‐Yuan, Yeh, Su‐Peng, Bai, Li‐Yuan, Liao, Yu‐Min, Lin, Chen‐Yuan, Hsieh, Ching‐Yun, Lin, Ching‐Chan, Lin, Che‐Hung, Lien, Ming‐Yu, Chen, Tzu‐Ting, Ni, Yen‐Hsuan, Chiu, Chang‐Fang
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2017
Sujets:
Clinical Cancer Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5313641/
https://ncbi.nlm.nih.gov/pubmed/28070990
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.969
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires